232 related articles for article (PubMed ID: 29293435)
21. Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.
Schmidt K; Nolte-Zenker B; Patzer J; Bauer M; Schmidt LG; Heinz A
Pharmacopsychiatry; 2001 Mar; 34(2):66-72. PubMed ID: 11302566
[TBL] [Abstract][Full Text] [Related]
22. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
[TBL] [Abstract][Full Text] [Related]
23. Anhedonia, self-experience in schizophrenia, and implications for treatment.
Juckel G; Sass L; Heinz A
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S176-80. PubMed ID: 14677076
[TBL] [Abstract][Full Text] [Related]
24. Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).
Blum K; Oscar-Berman M; Demetrovics Z; Barh D; Gold MS
Mol Neurobiol; 2014 Dec; 50(3):765-96. PubMed ID: 24878765
[TBL] [Abstract][Full Text] [Related]
25. Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
Blum K; Febo M; Thanos PK; Baron D; Fratantonio J; Gold M
Mol Neurobiol; 2015 Dec; 52(3):1862-1869. PubMed ID: 25750061
[TBL] [Abstract][Full Text] [Related]
26. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction.
Blum K; Thanos PK; Oscar-Berman M; Febo M; Baron D; Badgaiyan RD; Gardner E; Demetrovics Z; Fahlke C; Haberstick BC; Dushaj K; Gold MS
J Reward Defic Syndr; 2015; 1(3):95-104. PubMed ID: 27398406
[TBL] [Abstract][Full Text] [Related]
27. The role of dopamine in reward and pleasure behaviour--review of data from preclinical research.
Bressan RA; Crippa JA
Acta Psychiatr Scand Suppl; 2005; (427):14-21. PubMed ID: 15877719
[TBL] [Abstract][Full Text] [Related]
28. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies.
Volkow ND; Fowler JS; Wang GJ; Goldstein RZ
Neurobiol Learn Mem; 2002 Nov; 78(3):610-24. PubMed ID: 12559839
[TBL] [Abstract][Full Text] [Related]
29. Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword?
Blum K; Cadet JL; Baron D; Badgaiyan RD; Brewer R; Modestino EJ; Gold MS
Subst Use Misuse; 2020; 55(14):2438-2442. PubMed ID: 32957797
[TBL] [Abstract][Full Text] [Related]
30. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.
Gold MS; Badgaiyan RD; Blum K
Psychiatr Clin North Am; 2015 Sep; 38(3):419-62. PubMed ID: 26300032
[TBL] [Abstract][Full Text] [Related]
31. Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis.
Blum K; Khalsa J; Cadet JL; Baron D; Bowirrat A; Boyett B; Lott L; Brewer R; Gondré-Lewis M; Bunt G; Kazmi S; Gold MS
Front Psychiatry; 2021; 12():623403. PubMed ID: 33868044
[TBL] [Abstract][Full Text] [Related]
32. Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence.
Wang S; Leri F; Rizvi SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110289. PubMed ID: 33631251
[TBL] [Abstract][Full Text] [Related]
33. Does Anhedonia Presage Increased Risk of Posttraumatic Stress Disorder? : Adolescent Anhedonia and Posttraumatic Disorders.
Risbrough VB; Glynn LM; Davis EP; Sandman CA; Obenaus A; Stern HS; Keator DB; Yassa MA; Baram TZ; Baker DG
Curr Top Behav Neurosci; 2018; 38():249-265. PubMed ID: 29796839
[TBL] [Abstract][Full Text] [Related]
34. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y
Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
[TBL] [Abstract][Full Text] [Related]
35. Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits.
Liang S; Wu Y; Hanxiaoran L; Greenshaw AJ; Li T
Neuropsychiatr Dis Treat; 2022; 18():1385-1396. PubMed ID: 35836582
[TBL] [Abstract][Full Text] [Related]
36. Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.
Blum K; Oscar-Berman M; Badgaiyan RD; Palomo T; Gold MS
Med Hypotheses; 2014 May; 82(5):606-14. PubMed ID: 24636783
[TBL] [Abstract][Full Text] [Related]
37. Cocaine sensitization models an anhedonia-like condition in rats.
Scheggi S; Marchese G; Grappi S; Secci ME; De Montis MG; Gambarana C
Int J Neuropsychopharmacol; 2011 Apr; 14(3):333-46. PubMed ID: 20519061
[TBL] [Abstract][Full Text] [Related]
38. [Psychopathological correlates of dopaminergic dysfunction in alcoholic and schizophrenic patients].
Heinz A
Nervenarzt; 1999 May; 70(5):399-407. PubMed ID: 10407835
[TBL] [Abstract][Full Text] [Related]
39. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.
O'Sullivan SS; Evans AH; Lees AJ
CNS Drugs; 2009; 23(2):157-70. PubMed ID: 19173374
[TBL] [Abstract][Full Text] [Related]
40. Anticipation: An Essential Feature of Anhedonia.
Phillips AG; Ahn S
Curr Top Behav Neurosci; 2022; 58():305-323. PubMed ID: 35435641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
